dr. leach on brigatinib in alk-positive nsclc
Published 4 years ago • 280 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
8:47
dr uma dangi | brigatinib versus crizotinib in alk inhibitor naive advanced alk positive nsclc
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
1:34
dr. pennell on the use of brigatinib in alk nsclc
-
1:17
dr. bazhenova on the potential approval of lorlatinib for patients with alk-positive nsclc
-
1:38
dr. drilon on the safety profile of brigatinib in alk nsclc
-
5:14
1 cup will clear up mucus & phlegm in sinus, chest, and lungs | dr alan mandell, dc
-
2:18
【一表看清自費癌症藥物資助計劃詳情】
-
4:25
causes of constant phlegmy throat or throat mucus
-
1:21
nice approval of brigatinib in alk-positive nsclc
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
1:11
dr. rotow on brigatinib safety profile in alk nsclc
-
1:17
dr. xia on the frontline treatment landscape of alk-positive nsclc
-
6:58
alta-1l: brigatinib versus crizotinib for alk nsclc
-
1:14
dr. rotow on first-line brigatinib versus crizotinib in alk nsclc
-
4:38
alta ii: brigatinib in crizotinib-resistant alk nsclc
-
4:37
fda approval of brigatinib for alk nsclc
-
2:13
alk nsclc: brigatinib indication and alta trial
-
2:32
dr. shaw discusses ldk378 and alectinib (af802) for alk-positive nsclc
-
0:52
dr. rotow on remaining questions with brigatinib in alk nsclc
-
8:16
alta ii trial of brigatinib in alk-rearranged nsclc